Affinity Asset Advisors, LLC

Holdings History for Karyopharm Therapeutics Inc. - COMMON STOCK (KPTI)

Symbol: KPTI on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 1,713,092 shares
Security Ownership %: 8.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Affinity Asset Advisors, LLC ownership in Karyopharm Therapeutics Inc. COMMON STOCK (KPTI)

29 Jan 2026 - Affinity Asset Advisors, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,713,092 shares of Karyopharm Therapeutics Inc. COMMON STOCK (KPTI). This represents 8.6% ownership of the company. In their previous filing dated 10 Apr 2025, Affinity Asset Advisors, LLC had reported owning 664,224 shares, indicating an increase of +158%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Affinity Asset Advisors, LLC	8.6%	+9.6%	$12,870,974	1,713,092	+1,048,868	+158%	$7.51	13G/A	22 Jan 2026	29 Jan 2026, 21:32
Affinity Healthcare Fund, LP	7.8%		$4,217,822	664,224			$6.35	13G	03 Apr 2025	10 Apr 2025, 17:23

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.47%	+0.47%	$6,547,272	889,575	+889,575	NEW	$7.36	Q4 2025
31 Dec 2025	call		-1.4%	$0	0	-157,600	-100%	$8.94	Q4 2025
30 Sep 2025	call	1.4%	+0%	$1,030,704	157,600	+100	+0.06%	$6.54	Q3 2025
30 Jun 2025	call	1.2%	+1.2%	$678,825	157,500	+157,500	NEW	$4.31	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.